Last quarter (Q3 2025), 4D Molecular Therapeutics's total revenue was $90.00K, an increase of 2900.00% from the same quarter last year. In Q3, 4D Molecular Therapeutics's net income was $-56.88M. See 4D Molecular Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 37.00K	$ 20.72M	$ 3.13M	$ 18.04M	$ 13.61M
Gross Profit	$ 37.00K	$ -76.37M	$ -77.12M	$ -43.32M	$ -39.43M
Operating Expenses	$ 187.88M	$ 36.49M	$ 32.91M	$ 28.01M	$ 17.24M
Depreciation and Amortization	$ 6.71M	$ 4.20M	$ 2.40M	$ 1.52M	$ 1.44M
EBITDA	$ -181.14M	$ -108.66M	$ -107.63M	$ -69.81M	$ -55.22M
Operating Income	$ -187.84M	$ -112.87M	$ -110.03M	$ -71.33M	$ -56.66M
Other Income/Expenses	$ 26.97M	$ 12.03M	$ 2.54M	$ 16.00K	$ -29.00K
Pretax Income	$ -160.87M	$ -100.84M	$ -107.49M	$ -71.32M	$ -56.69M
Net Income	$ -160.87M	$ -100.84M	$ -107.49M	$ -71.32M	$ -56.69M
Per Share Metrics
Basic EPS	$ -2.98	$ -2.58	$ -3.12	$ -2.46	$ -2.12
Diluted EPS	$ -2.98	$ -2.58	$ -3.12	$ -2.46	$ -2.12
Weighted Average Shares Outstanding	53.94M	39.13M	32.35M	27.73M	26.68M
Weighted Average Shares Outstanding (Diluted)	53.94M	39.13M	32.35M	27.73M	26.68M

Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing